Rheumatology Email List | 28,940 Verified Contacts | SparkDBi
A rheumatology email list is a verified database of licensed rheumatologists, pediatric rheumatologists, rheumatology nurse practitioners, and rheumatology physician assistants, built from conference and CME partnerships, state and national professional association directories, healthcare publication networks, and B2B2C matching and verification programs. SparkDBi maintains 28,940 verified US rheumatology contacts across 8 subspecialties.
Trusted by 2,600+ world-class brands and organizations
SparkDBi maintains a verified rheumatology email list covering 28,940 rheumatologists, pediatric rheumatologists, rheumatology nurse practitioners, and clinical immunologists across the United States. Every contact is sourced from conference and CME partnerships, state licensing records, and professional association directories, then validated through email inbox verification, phone validation, and physical address confirmation. The database refreshes monthly.
Rheumatology is the central prescribing specialty for biologic and targeted synthetic DMARDs, the highest-value drug class in the autoimmune space. With the TNF inhibitor market now joined by IL-17 and IL-23 inhibitors, JAK inhibitors, and an expanding biosimilar landscape, reaching rheumatologists at the right practice type and subspecialty has become essential for life sciences commercial teams.
Conditions, Drugs, and Devices in Rheumatology
Rheumatoid arthritis (RA) is the highest-volume prescribing category. Methotrexate remains the anchor conventional DMARD, with biologics added in treatment-escalation protocols. TNF inhibitors (adalimumab, etanercept, infliximab, certolizumab pegol, golimumab) are the most widely prescribed biologics. IL-6 inhibitors (tocilizumab, sarilumab) and CTLA4-Ig (abatacept) address patients who fail TNF therapy. JAK inhibitors (tofacitinib, baricitinib, upadacitinib, filgotinib) have added an oral small-molecule option that competes directly with biologics in moderate-to-severe RA.
Psoriatic arthritis (PsA) and ankylosing spondylitis (AS) represent the second-largest prescribing category. IL-17 inhibitors (secukinumab, ixekizumab, bimekizumab) and IL-23 inhibitors (guselkumab, risankizumab) have emerged as first-line biologics in PsA, while TNF inhibitors and IL-17 inhibitors dominate AS. The PsA and AS markets are actively contested across all major biologic classes, requiring precise rheumatologist outreach separated from general RA targeting.
Systemic lupus erythematosus (SLE) is a high-complexity autoimmune condition with a limited treatment landscape that has expanded recently with belimumab (Benlysta), anifrolumab (Saphnelo), and voclosporin (Lupkynis) for lupus nephritis. SLE outreach requires filtering rheumatologists who manage complex connective tissue disease.
Gout is managed by rheumatologists for treatment-refractory cases requiring febuxostat, allopurinol titration, or pegloticase (Krystexxa) for chronic refractory tophaceous gout. Osteoporosis is treated by rheumatologists using bisphosphonates, denosumab (Prolia/Xgeva), romosozumab (Evenity), and teriparatide (Forteo) for patients with fragility fractures or high fracture risk.
Ultrasound devices for musculoskeletal imaging have been adopted by a growing segment of rheumatologists for joint assessment and guided injection. Point-of-care ultrasound (POCUS) manufacturers and distributors target rheumatologists at academic and large group practice settings.
Who Uses the Rheumatology Email List
Pharmaceutical companies with biologic DMARDs and JAK inhibitors represent the largest buyer segment. With more than 15 approved biologics competing in RA, PsA, and AS, companies running switch programs, adherence support, and new indication launches depend on precise rheumatologist segmentation to avoid wasteful broad-reach outreach.
Biosimilar companies are an expanding buyer. Adalimumab biosimilars (Hadlima, Hyrimoz, Cyltezo, Yusimry, Simlandi) have created an intensely competitive landscape requiring direct rheumatologist outreach to support formulary positioning and prescriber education. Etanercept, infliximab, and abatacept biosimilars have added further pressure on originator brands.
Medical device companies with musculoskeletal ultrasound systems, infusion chair and pump suppliers, and clinical software companies targeting rheumatology practices also use the list. CME providers producing rheumatology continuing education content use it for program promotion and faculty recruitment.
| Buyer | How They Use the Rheumatology List |
|---|---|
| Pharma - biologic DMARD | Rheumatologist outreach for RA biologic step-up protocols, targeting prescribers managing patients who have failed methotrexate monotherapy |
| Biosimilar company | Direct rheumatologist outreach for adalimumab biosimilar education and formulary positioning against originator adalimumab programs |
| Pharma - JAK inhibitor | Rheumatologist segmentation by practice type for oral JAK inhibitor programs in RA, PsA, and AS, filtered by prior biologic prescribing patterns |
| Pharma - SLE program | Rheumatologist list filtered for connective tissue disease and lupus subspecialty, targeting academic and large group practice settings |
| Device - POCUS | Rheumatology group practice and academic department outreach for point-of-care musculoskeletal ultrasound adoption programs |
Request Rheumatology Contact Data
Subspecialty filters, practice setting, sample records available
Rheumatology Subspecialties and Verified Contacts
The SparkDBi rheumatology database covers 8 subspecialty segments. All segments are available individually or in combination with subspecialty flags.
| Subspecialty | Provider Type | Contacts |
|---|---|---|
| Rheumatologist | Physician | 18,200 |
| Rheumatology Nurse Practitioner | Nurse Practitioner | 3,150 |
| Rheumatology Physician Assistant | Physician Assistant | 2,080 |
| Pediatric Rheumatologist | Physician | 1,490 |
| Clinical Immunologist | Physician | 1,320 |
| Osteoporosis and Metabolic Bone Disease Specialist | Physician | 980 |
| Musculoskeletal Radiologist | Physician | 850 |
| Rheumatology Clinical Pharmacist | Pharmacist | 870 |
All 8 subspecialty segments by verified contact count. Total: 28,940.
Geographic Coverage
The US rheumatology database covers all 50 states. Highest concentrations are in California, New York, Texas, and Florida, reflecting population density and the locations of major academic rheumatology programs and large group practices.
| State | Verified Contacts |
|---|---|
| California | 4,180 |
| New York | 3,420 |
| Texas | 2,650 |
| Florida | 2,310 |
| Pennsylvania | 1,740 |
| Ohio | 1,420 |
| Illinois | 1,290 |
| Massachusetts | 1,180 |
| North Carolina | 980 |
| Michigan | 870 |
International rheumatology data is available for the UK, Germany, France, Canada, and Australia. Contact SparkDBi for current counts by country.
Top Rheumatology Centers
Academic medical centers and large group practices represent the highest-value rheumatology outreach targets for biologics companies and medical device programs. SparkDBi can filter by institution type, practice size, and academic affiliation.
| Rank | Institution | Location |
|---|---|---|
| 1 | Hospital for Special Surgery | New York, NY |
| 2 | Mayo Clinic | Rochester, MN |
| 3 | Cleveland Clinic | Cleveland, OH |
| 4 | Johns Hopkins Hospital | Baltimore, MD |
| 5 | Brigham and Women's Hospital | Boston, MA |
| 6 | University of California San Francisco | San Francisco, CA |
| 7 | Duke University Medical Center | Durham, NC |
| 8 | University of Michigan | Ann Arbor, MI |
| 9 | Washington University in St. Louis | St. Louis, MO |
| 10 | University of Alabama Birmingham | Birmingham, AL |
How SparkDBi Sources and Verifies HCP Data
SparkDBi builds its HCP contact database from multiple vetted channels. Primary sources include conference attendance and CME event participation records from healthcare education partners, member directories from state and national professional associations, subscriber and contributor lists from healthcare publication networks, and B2B2C data matching and verification partnerships.
Publicly available sources including CMS and NPPES records are used as a cross-reference and comparison tool only. They are not a primary data source. CMS and NPPES data is frequently stale or out of date for direct contact purposes. SparkDBi treats it as one reference point among many rather than a source of record.
Verification runs across three dimensions. Email inbox verification connects directly to the receiving mail server and confirms the specific mailbox accepts incoming messages, without sending a message. Phone validation confirms work phone numbers are active and matched to the provider record. Physical address validation covers both work practice addresses and home addresses, with records that fail validation removed and replaced in the next monthly refresh cycle.
NPI Taxonomy Codes for Rheumatology
CMS NPI taxonomy codes for reference. These are useful when specifying subspecialty requirements or independently verifying provider credentials.
| Taxonomy Code | Classification |
|---|---|
| 207RR0500X | Rheumatology |
| 2080P0006X | Pediatrics - Rheumatology |
| 207RI0001X | Clinical and Laboratory Immunology (Internal Medicine) |
| 363L00000X | Nurse Practitioner (Rheumatology setting) |
| 363A00000X | Physician Assistant (Rheumatology setting) |
Practice Setting Breakdown
Rheumatology is dominated by private group practice and academic medical centre settings. Approximately 55% of rheumatologists in the SparkDBi database practice in private group settings or multi-specialty group practices. The remaining 45% are in academic hospital systems, federally qualified health centres, or hospital-employed positions.
Private-practice rheumatologists have more direct formulary flexibility compared to hospital-employed rheumatologists, who operate under health system pharmacy and therapeutics committee constraints. SparkDBi can filter by practice setting to target the population most relevant for each campaign objective.
Deliverability
Rheumatologists in private group practice use practice-domain email, which typically shows strong inbox placement. Academic and hospital-employed rheumatologists use enterprise email environments with more aggressive filtering. SparkDBi flags enterprise vs independent email domains in delivered datasets so buyers can apply domain-specific send strategies.
Data Enrichment and Available Fields
For existing rheumatology contact lists, SparkDBi can append or verify: NPI numbers, subspecialty classifications, practice setting, email addresses, practice addresses, and license status. Match rates average 71% against the full database.
Compliance
The SparkDBi rheumatology email list contains no patient data. All records are professional contact information for licensed rheumatology providers. The database is HIPAA-aligned, CAN-SPAM compliant, and CCPA-aware. Business Associate Agreements are available on request.